Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group [Original]

Shinkyo Yoon, Miso Kim, Yong Sang Hong, Han Sang Kim, Seung Tae Kim, Jihun Kim, Hongseok Yun, Changhoon Yoo, Hee Kyung Ahn, Hyo Song Kim, In Hee Lee, In-Ho Kim, Inkeun Park, Jae Ho Jeong, Jaekyung Cheon, Jin Won Kim, Jina Yun, Sun Min Lim, Yongjun Cha, Se Jin Jang, Dae Young Zang, Tae Won Kim, Jin Hyoung Kang, Jee Hyun Kim

Cancer Res Treat. 2023;55(3):1061-1061. Published online April 21, 2023 DOI: https://doi.org/10.4143/crt.2021.1115.E

Gastrointestinal cancer

A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer

Hyunji Jo, Seung Tae Kim, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Jeong Il Yu, Hee Chul Park, Doo Ho Choi, Yoonah Park, Yong Beom Cho, Jung Wook Huh, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Won Ki Kang

Cancer Res Treat. 2023;55(1):189-195. Published online June 8, 2022 DOI: https://doi.org/10.4143/crt.2021.1527

Web of Science 1 Crossref 1

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group

Cancer Res Treat. 2022;54(1):1-9. Published online December 13, 2021 DOI: https://doi.org/10.4143/crt.2021.1115

Web of Science 7 Crossref 8

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients

Youjin Kim, Tae Won Kim, Sae Won Han, Joong Bae Ahn, Seung Tae Kim, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Cancer Res Treat. 2019;51(3):1128-1134. Published online November 21, 2018 DOI: https://doi.org/10.4143/crt.2018.379

Web of Science 14 Crossref 9

Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols

Jeong Il Yu, Do Hoon Lim, Jeeyun Lee, Won Ki Kang, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Seung Tae Kim, Su Jin Lee, Sung Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Heejin Yoo, Kyunga Kim

Cancer Res Treat. 2019;51(3):876-885. Published online October 1, 2018 DOI: https://doi.org/10.4143/crt.2018.401

Web of Science 7 Crossref 6

A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology

Jun Ho Yi, Jung Hun Kang, In Gyu Hwang, Hee Kyung Ahn, Hyun Jin Baek, Soon Il Lee, Do Hyoung Lim, Young-Woong Won, Jun Ho Ji, Hyo Song Kim, Sun Young Rha, Sung Yong Oh, Kyung Eun Lee, Taekyu Lim, Chi Hoon Maeng, Moon Jin Kim, Seung Tae Kim, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Se Hoon Park

Cancer Res Treat. 2016;48(2):553-560. Published online August 10, 2015 DOI: https://doi.org/10.4143/crt.2015.155

Web of Science 18 Crossref 15

The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors

Moonjin Kim, Sujin Lee, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Won Ki Kang, Seung Tae Kim

Cancer Res Treat. 2016;48(1):153-161. Published online March 7, 2015 DOI: https://doi.org/10.4143/crt.2014.183

Web of Science 11 Crossref 9

Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?

Seung Tae Kim, Won Jin Chang, Lihua Jin, Jae Sook Sung, Yun Ji Choi, Yeul Hong Kim

Cancer Res Treat. 2015;47(4):796-803. Published online January 30, 2015 DOI: https://doi.org/10.4143/crt.2014.106

Web of Science 6 Crossref 5

Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer

Seung Tae Kim, Tae Won Kim, Kyu-pyo Kim, Tae-You Kim, Sae-Won Han, Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Haesu Kim, Young Suk Park

Cancer Res Treat. 2015;47(4):790-795. Published online December 2, 2014 DOI: https://doi.org/10.4143/crt.2014.126

Web of Science 13 Crossref 6

Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment

Jung Hyun Lee, Sung Gu Kang, Seung Tae Kim, Seok Ho Kang, In Keun Choi, Young Je Park, Sang Chul Oh, Deuk Jae Sung, Jae Hong Seo, Jun Cheon, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim, Kyong Hwa Park

Cancer Res Treat. 2014;46(2):172-177. Published online April 15, 2014 DOI: https://doi.org/10.4143/crt.2014.46.2.172

Web of Science 6 Crossref 6

Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?

Seung Tae Kim, Kyong Hwa Park, Sang Won Shin, Yeul Hong Kim

Cancer Res Treat. 2014;46(1):48-54. Published online January 15, 2014 DOI: https://doi.org/10.4143/crt.2014.46.1.48

Web of Science 12 Crossref 8

Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy

Seung Tae Kim, Kyong Hwa Park, Jun Suk Kim, Sang Won Shin, Yeul Hong Kim

Cancer Res Treat. 2013;45(1):55-62. Published online March 31, 2013 DOI: https://doi.org/10.4143/crt.2013.45.1.55

Crossref 12

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang

Cancer Res Treat. 2012;44(4):235-241. Published online December 31, 2012 DOI: https://doi.org/10.4143/crt.2012.44.4.235

Crossref 22

Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer

Seung Tae Kim, Kyong Hwa Park, Sang Cheul Oh, Jae Hong Seo, Jun Suk Kim, Yeul Hong Kim, Sang Won Shin

Cancer Res Treat. 2012;44(1):37-42. Published online March 31, 2012 DOI: https://doi.org/10.4143/crt.2012.44.1.37

Crossref 2

Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy

Jina Yun, Kyoung-Mee Kim, Seung Tae Kim, Jung-Hoon Kim, Jung A Kim, Jee Hyun Kong, Soo Hyeon Lee, Young-Woong Won, Jong-Mu Sun, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Cancer Res Treat. 2010;42(2):101-106. Published online June 30, 2010 DOI: https://doi.org/10.4143/crt.2010.42.2.101

Crossref 8